首页> 美国卫生研究院文献>Infection and Immunity >Construction of a diphtheria toxin A fragment-C180 peptide fusion protein which elicits a neutralizing antibody response against diphtheria toxin and pertussis toxin.
【2h】

Construction of a diphtheria toxin A fragment-C180 peptide fusion protein which elicits a neutralizing antibody response against diphtheria toxin and pertussis toxin.

机译:白喉毒素的构建一个片段C180肽融合蛋白该蛋白引起针对白喉毒素和百日咳毒素的中和抗体应答。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A genetically engineered gene fusion was constructed which encoded a nontoxic derivative of the A fragment of diphtheria toxin joined to the C180 peptide of the S1 subunit of pertussis toxin. The product of this gene fusion, termed the DTA-C180 protein, was purified from the periplasm of Escherichia coli to approximately 80% purity. The DTA-C180 protein possessed an apparent molecular weight of 43,000 by reduced sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The DTA-C180 protein was cleaved into two tryptic peptides, which migrated with apparent molecular weights of approximately 22,000. One tryptic peptide reacted with diphtheria antitoxin, while the other tryptic peptide reacted with anti-C180 peptide immunoglobulin G. The DTA-C180 protein did not inhibit protein synthesis or stimulate clustering morphology in Chinese hamster ovary cells. The DTA-C180 protein elicited an immune response, in guinea pigs, against both the DTA and C180 peptide components of the fusion protein, with alum being a more efficient adjuvant than Freund's adjuvant for eliciting neutralization titers. Neutralization titers elicited by DTA-C180 protein were weaker than those elicited by diphtheria toxoid and pertussis toxin 9K/129G, a genetically engineered double mutant of pertussis toxin. Three doses of DTA-C180 protein yielded a neutralization titer of 1/750 against pertussis toxin in Chinese hamster ovary cells and a neutralization titer of 1/50 against diphtheria toxin in Vero cells. This is the first report of a protein derived from a recombinant S1 subunit that elicits a neutralizing titer against pertussis toxin.
机译:构建了基因工程的基因融合体,其编码与百日咳毒素的S1亚基的C180肽连接的白喉毒素A片段的无毒衍生物。从大肠杆菌的周质中纯化出该基因融合产物,称为DTA-C180蛋白,其纯度约为80%。通过还原的十二烷基硫酸钠-聚丙烯酰胺凝胶电泳,DTA-C180蛋白的表观分子量为43,000。 DTA-C180蛋白被切割成两个胰蛋白酶肽,它们以大约22,000的表观分子量迁移。一种胰蛋白酶肽与白喉抗毒素反应,而另一种胰蛋白酶肽与抗C180肽免疫球蛋白G反应。DTA-C180蛋白不抑制蛋白合成或刺激中国仓鼠卵巢细胞的聚集形态。 DTA-C180蛋白在豚鼠中引发针对融合蛋白的DTA和C180肽成分的免疫反应,明矾比弗氏佐剂更有效地引发中和效价。 DTA-C180蛋白引起的中和效价比白喉类毒素和百日咳毒素9K / 129G(百日咳毒素的基因工程双突变体)引起的中和效价弱。三剂DTA-C180蛋白在中国仓鼠卵巢细胞中对百日咳毒素的中和效价为1/750,在Vero细胞中对白喉毒素的中和效价为1/50。这是源自重组S1亚基的蛋白的首次报道,该蛋白引发针对百日咳毒素的中和效价。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号